1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6047E2FF729E866328525800C003E7F90
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/critical-strategies-develop-strong-medical-information-groups
18
19
20172.70.100.214
21
22
23527255.sherryhk.tech
24/bestp/domrep.nsf
25BMR




» Products & Services » » Medical Affairs » Medical Communication

Critical Strategies to Develop Strong Medical Information Groups

ID: POP-276


Features:

12 Info Graphics

22 Data Graphics

250+ Metrics

10 Narratives


Pages: 47


Published: Pre-2019


Delivery Format: Shipped


 

License Options:


Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • VIEW TOC AND LIST OF EXHIBITS
Medical Information groups are an integral part of the medical discussion and collection of information from physicians, patients and payers. Medical Information teams shoulder greater responsibilities in addressing key concerns regarding commercial drugs and developing sales training and promotional materials.


However, the Medical Affairs function needs to ensure that its Medical Information activities are aligned with compliance requirements owing to stringent regulations in the industry.

Best Practices, LLC undertook benchmarking research to identify critical requirements for the Medical Affairs function to create successful Medical Information groups. The study provides benchmarks around the structure and leadership of Medical Information groups, and alignment of information activities with compliance requirements. It also delivers benchmarks around the required resource levels to create strong Medical Information groups and ways for efficient internal collaboration.


Industries Profiled:
Pharmaceutical; Biopharmaceutical; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Health Care


Companies Profiled:
Abbvie; Alnylam Pharmaceuticals; Astellas; AstraZeneca; Baxalta; Bayer; Boehringer Ingelheim; CSL Behring; Ferring Pharmaceuticals; Galderma; GW Pharmaceuticals; Incyte; Janssen; Lundbeck; Merck; Novartis; Neurocrine Biosciences; Pierre Fabre Medicament; ProStrakan; Pfizer; Sunovion; Teva Pharmaceutical Industries Ltd; Tillotts Pharma; Upsher-Smith; Xenoport

Study Snapshot

Best Practices, LLC engaged 26 executives from 25 leading biopharmaceutical companies for this benchmarking research. Three high-level Medical Information executives were interviewed to capture qualitative insights.

Eleven research participants represented large biopharmaceutical organizations, while 8 participants represented medium companies and the remaining benchmark class emerged from small companies.

Key Findings


· Current Structure and Leadership:

    Ø Medical Information groups structures are usually either Centralized or Hybrid organizations. 84% of participants’ Medical Information groups have either centralized or hybrid structure.

    Ø 69% of the Medical Information groups in the study have director-level leadership. Having high-level leaders illustrates the importance of Medical Information groups.

· Internal Collaboration:

The top two groups that Medical Information collaborates with are: Medical Science Liaison teams and Pharmacovigilance departments.
Table of Contents

I.
Executive Summary
pgs. 3-9
Research Overview
pg. 3
Participating Companies Segmentation
pgs. 4-5
Key Recommendations
pg. 6
Key Findings & Insights
pgs. 7-9
II.
Structure and leadership
pgs. 10-11
III.
Compliance and Information Sharing
pgs. 12-15
IV.
Medical Information Activities
pgs. 16-22
V.
Collaboration
pgs. 23-32
VI.
Challenges and Importance of Actions
pgs. 33-39
VII.
Resource Benchmarks
pgs. 40-43
VIII.
Demographics and TA Focus
pgs. 44-46
IX.
About Best Practices, LLC
pg. 47

    List of Charts & Exhibits

    • Current Structure and Leadership Level of the Medical Information Group at Participating Companies
    • Compliance Guidelines and Rules Utilized for Medical Information Activities
    • Types of Information Shared with Payers and Providers for the Purposes of Compliance
    • Medical Information Activities Involvement Score
    • Case Example: Developing a Self-Service Portal for Health Care Providers (HCPs)
    • Importance of Listed Medical Information Activities
    • Collaboration of Medical Affairs and Legal Departments: Legal Department's Role in Reviewing the Medical Information Letters
    • Key Challenges Posed by Social Media Channel
    • Medical Information Groups’ Internal Collaboration Scores
    • Communication to Field-Based Teams
    • Importance of Partnerships with different Functions for the Medical Information Group
    • Three Important Action Items for Clear Medical Information Flow
    • Challenges faced by the Medical Information Group
    • Drivers of Documentation Time
    • Important Capabilities for Medical Information Groups
    • Sales Revenue per Medical Information FTE
    • Medical Information Budget as a Percentage of Medical Affairs Spend
    • Medical Information FTE as a Percentage of Medical Affairs FTE